id,drug1,object,drug2,precipitant,certainty,contraindication,dateAdded,ddiPkEffect,ddiPkMechanism,effectConcept,homepage,label,numericVal,objectUri,pathway,precaution,precipUri,severity,uri,whoAnnotated,source,ddiType,evidence,evidenceSource,evidenceStatement,researchStatementLabel,researchStatement,managementOptions
17345,http://bio2rdf.org/drugbank:DB01026,Ketoconazole,http://bio2rdf.org/drugbank:DB00682,Warfarin,None,None,None,None,None,None,None,"Ketoconazole, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if ketoconazole is initiated, discontinued or dose changed.|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
24103,http://bio2rdf.org/drugbank:DB01026,Ketoconazole,http://bio2rdf.org/drugbank:DB01076,Atorvastatin,None,None,None,None,None,None,None,"Increased risk of myopathy/rhabdomyolysis|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
24774,http://bio2rdf.org/drugbank:DB01026,Ketoconazole,http://bio2rdf.org/drugbank:DB00227,Lovastatin,None,None,None,None,None,None,None,"Increased risk of myopathy/rhabdomyolysis|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
26357,http://bio2rdf.org/drugbank:DB01026,Ketoconazole,http://bio2rdf.org/drugbank:DB00227,LOVASTATIN,None,None,None,None,None,None,None,"KETOCONAZOLE/LOVASTATIN [VA Drug Interaction]",None,None,None,None,None,Critical,http://purl.bioontology.org/ontology/NDFRT/N0000033990,None,NDF-RT,None,None,None,None,None,None,None
40112,http://bio2rdf.org/drugbank:DB01026,Ketoconazole,http://bio2rdf.org/drugbank:DB01098,Rosuvastatin,None,None,None,None,unclassified,None,None,None,None,None,None,True,None,None,http://rest.kegg.jp/ddi/D00351,None,Kegg,None,None,None,None,None,None,None
